MARI ASPER: Open Payments
NPI 1073710786 · NORTH CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,394 in 61 payments from 17 companies in 2025. Trend: 2023 $1,746 · 2024 $1,546 · 2025 $1,394
Food & beverage: $1,394
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $217 |
| Axsome Therapeutics, Inc. | 3 | $187 |
| Otsuka America Pharmaceutical, Inc. | 4 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $117 |
| Collegium Pharmaceutical, Inc. | 5 | $88 |
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
| Almatica Pharma LLC | 4 | $82 |
| Supernus Pharmaceuticals, Inc. | 4 | $78 |
| Corium, LLC | 2 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
Products named: REXULTI, VRAYLAR, Auvelity, CAPLYTA, Jornay PM, COBENFY, LOREEV XR, Qelbree.
Industry payments across SC — which companies pay providers there.
